MERIDIAN BIOSCIENCE, INC. Revenue
MERIDIAN BIOSCIENCE, INC. reported Revenue of $56.90 million for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-09.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2023-02-09
- MERIDIAN BIOSCIENCE, INC. revenues for the quarter ending 2022-12-31 was $56.90M, a 35.59% decline year-over-year.
- MERIDIAN BIOSCIENCE, INC. revenues for the quarter ending 2022-09-30 was $65.67M, a 13.82% decline year-over-year.
- MERIDIAN BIOSCIENCE, INC. revenues for the quarter ending 2022-06-30 was $67.77M, a 6.71% increase year-over-year.
- MERIDIAN BIOSCIENCE, INC. revenues for the quarter ending 2022-03-31 was $111.23M, a 30.45% increase year-over-year.
- MERIDIAN BIOSCIENCE, INC. revenues for fiscal 2022 was $333.02M, a 4.76% increase from fiscal 2021.
- MERIDIAN BIOSCIENCE, INC. revenues for fiscal 2021 was $317.90M, a 25.32% increase from fiscal 2020.
- MERIDIAN BIOSCIENCE, INC. revenues for fiscal 2020 was $253.67M, a 26.19% increase from fiscal 2019.
- MERIDIAN BIOSCIENCE, INC. revenues for fiscal 2019 was $201.01M, a 5.88% decline from fiscal 2018.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2022-12-31 | $56.90M 10-Q · filed 2023-02-09 | $122.58M derived: sum of 2 quarters · filed 2023-02-09 | $190.35M derived: sum of 3 quarters · filed 2023-02-09 | $301.58M derived: sum of 4 quarters · filed 2023-02-09 |
| 2022-09-30 | $65.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $133.45M derived: sum of 2 quarters · filed 2022-11-22 | $244.68M derived: sum of 3 quarters · filed 2022-11-22 | $333.02M 10-K · filed 2022-11-22 |
| 2022-06-30 | $67.77M 10-Q · filed 2022-08-05 | $179.00M derived: sum of 2 quarters · filed 2022-08-05 | $267.34M 10-Q · filed 2022-08-05 | $343.55M derived: sum of 4 quarters · filed 2023-02-09 |
| 2022-03-31 | $111.23M 10-Q · filed 2022-05-06 | $199.57M 10-Q · filed 2022-05-06 | $275.78M derived: sum of 3 quarters · filed 2023-02-09 | $339.29M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-12-31 | $88.34M 10-Q · filed 2023-02-09 | $164.54M derived: sum of 2 quarters · filed 2023-02-09 | $228.06M derived: sum of 3 quarters · filed 2023-02-09 | $313.32M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | $76.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $139.72M derived: sum of 2 quarters · filed 2022-11-22 | $224.98M derived: sum of 3 quarters · filed 2022-11-22 | $317.90M 10-K · filed 2022-11-22 |
| 2021-06-30 | $63.51M 10-Q · filed 2022-08-05 | $148.78M derived: sum of 2 quarters · filed 2022-08-05 | $241.69M 10-Q · filed 2022-08-05 | $305.85M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $85.26M 10-Q · filed 2022-05-06 | $178.18M 10-Q · filed 2022-05-06 | $242.33M derived: sum of 3 quarters · filed 2022-05-06 | $327.13M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $92.92M 10-Q · filed 2022-02-04 | $157.07M derived: sum of 2 quarters · filed 2022-02-04 | $241.87M derived: sum of 3 quarters · filed 2022-02-04 | $299.16M derived: sum of 4 quarters · filed 2022-02-04 |
| 2020-09-30 | $64.15M 10-K · filed 2020-11-23 | $148.95M derived: sum of 2 quarters · filed 2021-08-06 | $206.25M derived: sum of 3 quarters · filed 2021-08-06 | $253.67M 10-K · filed 2022-11-22 |
| 2020-06-30 | $84.80M 10-Q · filed 2021-08-06 | $142.09M derived: sum of 2 quarters · filed 2021-08-06 | $189.51M 10-Q · filed 2021-08-06 | $240.36M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $57.30M 10-Q · filed 2021-05-07 | $104.72M 10-Q · filed 2021-05-07 | $155.56M derived: sum of 3 quarters · filed 2021-05-07 | $204.00M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $47.42M 10-Q · filed 2021-02-05 | $98.27M derived: sum of 2 quarters · filed 2021-02-05 | $146.71M derived: sum of 3 quarters · filed 2021-02-05 | $196.96M derived: sum of 4 quarters · filed 2021-02-05 |
| 2019-09-30 | $50.85M 10-K · filed 2020-11-23 | $99.29M derived: sum of 2 quarters · filed 2020-11-23 | $149.53M derived: sum of 3 quarters · filed 2020-11-23 | $201.01M 10-K · filed 2021-11-23 |
| 2019-06-30 | $48.44M 10-K · filed 2020-11-23 | $98.69M derived: sum of 2 quarters · filed 2020-11-23 | $150.17M 10-Q · filed 2020-08-07 | $203.27M derived: sum of 4 quarters · filed 2020-11-23 |
| 2019-03-31 | $50.25M 10-K · filed 2020-11-23 | $101.73M 10-Q · filed 2020-05-08 | $154.83M derived: sum of 3 quarters · filed 2020-11-23 | $206.56M derived: sum of 4 quarters · filed 2020-11-23 |
| 2018-12-31 | $51.48M 10-K · filed 2020-11-23 | $104.58M derived: sum of 2 quarters · filed 2020-11-23 | $156.32M derived: sum of 3 quarters · filed 2020-11-23 | $212.77M derived: sum of 4 quarters · filed 2020-11-23 |
| 2018-09-30 | $53.10M 10-K · filed 2019-11-26 | $104.84M derived: sum of 2 quarters · filed 2019-11-26 | $161.29M derived: sum of 3 quarters · filed 2019-11-26 | $213.57M 10-K · filed 2020-11-23 |
| 2018-06-30 | $51.74M 10-K · filed 2019-11-26 | $108.19M derived: sum of 2 quarters · filed 2019-11-26 | $160.47M 10-Q · filed 2019-08-07 | $210.17M derived: sum of 4 quarters · filed 2019-11-26 |
| 2018-03-31 | $56.45M 10-K · filed 2019-11-26 | $108.73M 10-Q · filed 2019-05-07 | $158.43M derived: sum of 3 quarters · filed 2019-11-26 | $208.57M derived: sum of 4 quarters · filed 2019-11-26 |
| 2017-12-31 | $52.28M 10-K · filed 2019-11-26 | $101.98M derived: sum of 2 quarters · filed 2019-11-26 | $152.12M derived: sum of 3 quarters · filed 2019-11-26 | $206.25M derived: sum of 4 quarters · filed 2019-11-26 |
| 2017-09-30 | $49.70M 10-K · filed 2018-11-29 | $99.84M derived: sum of 2 quarters · filed 2018-11-29 | $153.96M derived: sum of 3 quarters · filed 2018-11-29 | $200.77M 10-K · filed 2019-11-26 |
| 2017-06-30 | $50.14M 10-K · filed 2018-11-29 | $104.27M derived: sum of 2 quarters · filed 2018-11-29 | $151.07M 10-Q · filed 2018-08-09 | |
| 2017-03-31 | $54.13M 10-K · filed 2018-11-29 | $100.93M derived: sum of 2 quarters · filed 2018-11-29 | ||
| 2016-12-31 | $46.81M 10-K · filed 2018-11-29 | |||
| 2016-09-30 | $196.08M 10-K · filed 2018-11-29 |